Victory Capital Management
ORGS

Victory Capital Management’s Orgenesis Inc. Common Stock ORGS Stock Holding History

Victory Capital Management’s Portfolio ORGS Stock Details ORGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-469
Closed -$18K – 3384
2020
Q1 		$18K Buy
+469
New +$20.5K ﹤0.01% 3139
2019
Q4 		– Sell
-235
Closed -$11K – 3372
2019
Q3 		$11K Buy
+235
New +$10.5K ﹤0.01% 3238

Other funds holding ORGS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Victory Capital Management's ORGS Position: Q2 2020 in Review

Victory Capital Management sold out of Orgenesis Inc. Common Stock (ORGS) in Q2 2020, closing a stake of 469 shares — an estimated $18K sold.

Victory Capital Management first reported a position in ORGS in Q3 2019 and held it in 2 quarters. The position peaked at $18K in Q1 2020. 40 funds tracked by Wall St. Rank hold ORGS as of Q2 2020.

  • Victory Capital Management reported no remaining Orgenesis Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Victory Capital Management sold 469 Orgenesis Inc. Common Stock shares in Q2 2020, an estimated $18K.
  • Victory Capital Management first reported a position in Orgenesis Inc. Common Stock in Q3 2019 and held it in 2 quarters.
  • Victory Capital Management's Orgenesis Inc. Common Stock position peaked at $18K in Q1 2020.
  • 40 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.